Adipocytokines, sex hormones, and cardiovascular risk factors in postmenopausal women: Factor analysis of the rancho Bernardo study

Hormone and Metabolic Research

Volumn 41, Issue 10, 2009, Pages 773-777

  Krentz, A J ^a   Mühlen, D Von ^a   Barrett Connor, E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adiponectin; Androgens; Cardiovascular disease; Insulin; Leptin; Menopause

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; ESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; PRASTERONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CAUCASIAN; COHORT ANALYSIS; COMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; FACTORIAL ANALYSIS; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; OBESITY; OVARY; POSTMENOPAUSE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

ADIPONECTIN; AGED; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL; COHORT STUDIES; ESTRADIOL; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; INSULIN; INTERLEUKIN-6; LEPTIN; MIDDLE AGED; POSTMENOPAUSE; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 70350367147     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0029-1224104     Document Type: Article

References (31)

1. Ren J. Leptin and hyperleptinemia from friend to foe for cardiovascular function. J Endocrinol 2004 181 1-10
2. Jacobs HS, Conway GS. Leptin, polycystic ovaries and polycystic ovary syndrome. Hum Reprod Update 1999 5 166-171
3. Orio Jr F, Palomba S, Cascella T, Milan G, Mioni R, Pagano C, Zullo F, Colao A, Lombardi G, Vettor R. Adiponectin levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003 88 2619-2623 (Pubitemid 36724434)
4. Rathmann W, Herder C. Adiponectin and cardiovascular mortality: evidence for reverse epidemiology Horm Metab Res 2007 39 1-2
5. Dekker JM, Funahashi T, Nijpels G, Pilz S, Stehouwer DC, Snijder MB, Bouter LM, Matsuzawa Y, Shimomura I, Heine RJ. Prognostic value of adiponectin for cardiovascular disease and mortality. J Clin Endocrinol Metab 2008 93 1489-1496
6. Kizer JR, Barzilay JI, Kuller LH, Gottdiener JS. Adiponectin and risk of coronary heart disease in older men and women. J Clin Endocrinol Metab 2008 93 3357-3364
7. Spranger J, Möhlig M, Wegewitz U, Ristow M, Pfeiffer AF, Schill T, Schlösser HW, Brabant G, Schöfl C. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2004 61 738-746
8. Tsilchorozidou T, Overton C, Conway GS. The pathophysiology of polycystic ovary syndrome. Clin Endocrinol (Oxf) 2004 60 1-17
9. Legro RS. Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev 2003 24 302-312
10. Wu FC, von Eckardstein A. Androgens and coronary artery disease. Endocr Rev 2003 24 183-217
11. Arnal JF, Bayard F. Vasculoprotective effects of oestrogens. Clin Exp Pharmacol Physiol 2001 28 1032-1034
12. Krentz AJ, von Muhlen D, Barrett-Connor E. Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease. Menopause 2007 14 284-292
13. Rosner W. A simplified method for the quantitative determination of testosterone-estradiol-binding globulin activity in human plasma. J Clin Endocrinol Metab 1972 34 983-988
14. Tremblay RR, Dube JY. Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives. Contraception 1974 10 599-605
15. Goodman-Gruen D, Barrett-Connor E. Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care 2000 23 912-918
16. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000 23 57-63
17. Lipid Research Clinics Program (US). Laboratory Methods Committee Bethesda, Md.: National Heart and Lung Institute, National Institutes of Health (DHEW Publication No 75-628) 1974
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 18 499-502
19. Lawlor DA, Ebrahim S, May M, Davey Smith G. (Mis)use of factor analysis in the study of insulin resistance syndrome. Am J Epidemiol 2004 159 1013-1018
20. Hajamor S, Despres JP, Couillard C, Lemieux S, Tremblay A, Prudhomme D, Tchernof A. Relationship between sex hormone-binding globulin levels and features of the metabolic syndrome. Metabolism 2003 52 724-730
21. Tworoger SS, Mantzoros C, Hankinson SE. Relationship of plasma adiponectin with sex hormone and insulin-like growth factor levels. Obesity (Silver Spring) 2007 15 2217-2224
22. Fischer-Posovszky P, Wabitsch M, Hochberg Z. Endocrinology of adipose tissue an update. Horm Metab Res 2007 39 314-321
23. Lara-Castro C, Fu Y, Chung BH, Garvey WT. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol 2007 18 263-270
24. Verges B, Petit JM, Duvillard L, Dautin G, Florentin E, Galland F, Gambert P. Adiponectin is an important determinant of apoA-I catabolism. Arterioscler Thromb Vasc Biol 2006 26 1364-1369
25. Sowers JR. Obesity as a cardiovascular risk factor. Am J Med 2003 115 (Suppl 8A) 37S-41S
26. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T, Matsuzawa Y. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002 51 2734-2741
27. Casabiell X, Pineiro V, Vega F, De La Cruz LF, Dieguez C, Casanueva FF. Leptin, reproduction and sex steroids. Pituitary 2001 4 93-99
28. Leyva F, Godsland IF, Ghatei M, Proudler AJ, Aldis S, Walton C, Bloom S, Stevenson JC. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 1998 18 928-933 (Pubitemid 28272587)
29. Ford ES. Factor analysis and defining the metabolic syndrome. Ethn Dis 2003 13 429-437
30. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, Engel J, Brownlee M, Scherer PE. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 2003 278 9073-9085
31. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA, Scherer PE. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004 279 12152-12162